Hematology CME

Credits: 0.50 CME / MOC
Penn State College of Medicine
Expanding Options for Prophylaxis and Treatment of Acute and Chronic GVHD: Mapping the Path to Better Patient Outcomes in Post-Transplant Care
Miguel-Angel Perales, MD
31 December, 2019
Credits: 1.50 CPE
Medical Learning Institute, Inc.
Exploring Emerging Strategies in the Management of Anemia in Chronic Kidney Disease
Jay B. Wish, MD
31 December, 2019
Credits: 2.00 CME
Medical Learning Institute, Inc.
How I Think, How I Treat: BTK Inhibitors as a Clinical Strategy in CLL, MCL, and Beyond—Therapeutic Selection, Sequencing, and Next Steps
Andre H. Goy, MD
30 December, 2019
Credits: 1.50 CME
Medical Learning Institute, Inc.
Recognizing and Managing Hemophilia in the Emergency Department in an Era of Expanding Therapeutic Options: A Progress-in-Practice MasterClass and Practicum
Sarah Luisa Melendez, MD / Doris Quon, MD, PhD
2 December, 2019
Credits: 1.50 CME
Penn State College of Medicine
Innovative Therapy for B-Cell Malignancies: A MasterClass and Tumor Board on Decision-Making in CLL, FL, and MCL
Ian W. Flinn, MD, PhD
28 October, 2019
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Pathology Insights on Innovation in AML: The Rapid Emergence of Precision Diagnostics & Novel Therapy Across the Spectrum of Care
Carlos E. Bueso-Ramos, MD, PhD
28 October, 2019
Credits: 0.50 CME / MOC / CNE
Medical Learning Institute, Inc.
The Oncology Team and Secondary AML: Conversations on New Science and Its Effect on Patient Care
Stephen A. Strickland, MD, MSCI
18 September, 2019
Credits: 1.00 CME / CNE
Penn State College of Medicine
Driving Change in Multiple Myeloma: Updates on Novel Agent Classes and Next-Generation Therapeutics
Robert Z. Orlowski, MD, PhD
8 August, 2019
Credits: 0.50 CME
Penn State College of Medicine
Taking a New Look at Mantle Cell Lymphoma in the Era of Novel Agent Classes: From Innovative Concepts to Practical Applications of Evidence
John Allan, MD
17 July, 2019
Credits: 2.00 CME
Penn State College of Medicine
A MasterClass on Innovative Therapy in B-Cell Lymphoma: Evidence, Clinical Guidance, and Insights on the Future of Patient Care
Nathan H. Fowler, MD
3 July, 2019
Credits: 0.50 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Taking a New Look at Cancer-Associated Venous Thromboembolism: How Is Emerging Evidence Influencing Guidelines & Practice?
Robert D. McBane, MD
25 June, 2019
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Changing the Treatment Story in Myelofibrosis: New Science and More Choices for Challenging Cases in the JAK Inhibitor Era
Professor Claire Harrison, MD
25 June, 2019
Credits: 1.00 CME / CNE / CPE
Penn State College of Medicine / Medical Learning Institute, Inc.
The Emergence of Oral Therapy as a Pillar of Care in B-Cell Lymphoma: Insights and Expert Opinions From the Hematology-Oncology Team
Nathan H. Fowler, MD
21 June, 2019
Credits: 0.50 CME
University of Cincinnati
Recognizing and Treating Iron Deficiency in Patients With Heart Failure: Achieving Better Outcomes and Quality of Life
Adrian Hernandez, MD, MHS
12 June, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Addressing Unmet Needs in Managing Anemia in Chronic Kidney Disease: A Closer Look at the Clinical Potential of HIF-PH Inhibitors
Jay B. Wish, MD
11 June, 2019
Credits: 1.50 CNE
Medical Learning Institute, Inc.
Navigating the CAR-T Cell Therapy Landscape in Hematologic Malignancies: Science and Practical Issues in Nursing Care
Susan Blumel, RN, BSN
24 May, 2019
Credits: 1.50 CME / CNE
Penn State College of Medicine / Medical Learning Institute, Inc.
An Oncology Nurse MasterClass on Oral Therapy in B-Cell Malignancies: Insights on Evidence, Practical Strategies, and the Nurse-Patient Partnership
Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC
22 May, 2019
Credits: 1.50 CNE / CE
Medical Learning Institute, Inc.
Taking Aim at B-Cell Malignancies With BTK Inhibitors: Oncology Nurse Perspectives and Insights on Clinical Care
Mollie Moran, APRN-CNP, AOCNP
16 May, 2019
Credits: 1.50 CME / CNE
Penn State College of Medicine
BTK Inhibition as an Anti-Cancer Strategy: Exploring a Model for Modern Targeted Therapy in Hematologic Malignancies and Beyond
John C. Byrd, MD
6 May, 2019
Credits: 1.00 CME / CNE
Penn State College of Medicine / Medical Learning Institute, Inc.
Oncology Nurse Insights Into New Agent Classes and Research in B-Cell Lymphoma: Practical Issues and Evidence for the Front-Lines of Care
Amy Goodrich, NP
30 April, 2019
Credits: 1.00 CME
Medical Learning Institute, Inc.
Progress and Promise With Immunotherapy in Resectable Melanoma: Exploring New Evidence and Practical Issues With Checkpoint Inhibitors as Adjuvant Therapy
Jason J. Luke, MD, FACP / Jennifer Wargo, MD, MMSc
25 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Innovative Therapeutic Concepts for ASCT-Eligible Patients With Myeloma: Advancing Toward More Effective Care Across Treatment Settings
Sagar Lonial, MD, FACP
10 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Attacking the Clinical Problem of VOD/SOS in HCT Recipients: Insights on Pathophysiology, Diagnosis, and Treatment
Mitchell Cairo, MD
3 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Harnessing Recent Advances in CAR-T Cell Therapy for Leukemia and Lymphoma in the Era of Stem Cell Transplantation
Tanya Siddiqi, MD / Shannon L. Maude, MD, PhD
2 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Integrating Innovative Therapeutics With Allogeneic HCT in AML: Insights and Evidence From Induction to Maintenance
Alexander Perl, MD / James M. Foran, MD, FRCPC
29 March, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Innovative Therapies in Post-Transplant GVHD: Personal Insights From the Patient CaseBook
Madan Jagasia, MBBS, MS, MMHC
28 March, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Managing CMV in the New Era of Antiviral Therapy: Practical Considerations in the HCT Setting
Roy Chemaly, MD, MPH, FIDSA, FACP
26 March, 2019
Credits: 0.50 CME
University of Nebraska Medical Center
Exploring Clinical Decisions in the New Era of Myeloma Management: The Impact of Novel Platforms and Agent Classes Across the Spectrum of Care
Luciano J. Costa, MD, PhD
13 March, 2019
Credits: 0.50 CME
Penn State College of Medicine
Defining the Role of Extended Half-Life Replacement Clotting Factors in the Modern Management of Hemophilia A
Guy Young, MD
25 February, 2019
Credits: 1.00 CME / CNE
Penn State College of Medicine / Medical Learning Institute, Inc.
Building Innovative Treatment Options for Patients With B-Cell Malignancies: Practical Insights on Clinical Evidence and Integration Strategies
Nathan Fowler, MD
15 February, 2019

Pages